These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the quarterly period ended September 30, 2014
|
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the Transition Period from to
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
|
76-0346924
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification Number)
|
|
Large accelerated filer
|
|
x
|
|
Accelerated filer
|
|
¨
|
|
Non-accelerated filer
|
|
¨
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
|
¨
|
|
|
|
|
Item
|
Page
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30,
2014 |
|
December 31,
2013 |
||||
|
|
|
|
|
|
||||
|
|
|
(in thousands of dollars, except
par values and share amounts)
|
||||||
|
ASSETS
|
|
|
|
|
||||
|
Current assets
|
|
|
|
|
||||
|
Cash and cash equivalents
|
|
$
|
813,468
|
|
|
$
|
461,301
|
|
|
Marketable securities
|
|
—
|
|
|
239,388
|
|
||
|
Accounts receivable, net
|
|
592,964
|
|
|
428,457
|
|
||
|
Inventories
|
|
500,552
|
|
|
471,879
|
|
||
|
Prepaid expenses and other current assets
|
|
18,884
|
|
|
13,888
|
|
||
|
Deferred income taxes
|
|
26,080
|
|
|
34,169
|
|
||
|
Total current assets
|
|
1,951,948
|
|
|
1,649,082
|
|
||
|
Property, plant and equipment, net
|
|
2,710,475
|
|
|
2,088,014
|
|
||
|
Equity investments
|
|
70,828
|
|
|
66,875
|
|
||
|
Other assets, net
|
|
|
|
|
||||
|
Intangible assets, net
|
|
222,728
|
|
|
159,046
|
|
||
|
Deferred charges and other assets, net
|
|
170,304
|
|
|
97,892
|
|
||
|
Total other assets, net
|
|
393,032
|
|
|
256,938
|
|
||
|
Total assets
|
|
$
|
5,126,283
|
|
|
$
|
4,060,909
|
|
|
LIABILITIES AND EQUITY
|
|
|
|
|
||||
|
Current liabilities
|
|
|
|
|
||||
|
Accounts payable
|
|
$
|
263,365
|
|
|
$
|
249,613
|
|
|
Accrued liabilities
|
|
309,671
|
|
|
155,245
|
|
||
|
Total current liabilities
|
|
573,036
|
|
|
404,858
|
|
||
|
Long-term debt
|
|
763,968
|
|
|
763,879
|
|
||
|
Deferred income taxes
|
|
513,773
|
|
|
437,976
|
|
||
|
Other liabilities
|
|
153,158
|
|
|
35,593
|
|
||
|
Total liabilities
|
|
2,003,935
|
|
|
1,642,306
|
|
||
|
Commitments and contingencies (Notes 7 and 15)
|
|
|
|
|
|
|
||
|
Stockholders' equity
|
|
|
|
|
||||
|
Preferred stock, $0.01 par value, 50,000,000 shares authorized;
no shares issued and outstanding
|
|
—
|
|
|
—
|
|
||
|
Common stock, $0.01 par value, 300,000,000 shares authorized;
134,680,164 and 134,580,208 shares issued at September 30, 2014
and December 31, 2013, respectively (Note 1)
|
|
1,347
|
|
|
1,346
|
|
||
|
Common stock, held in treasury, at cost; 1,220,544 and 1,252,922 shares
at September 30, 2014 and December 31, 2013, respectively (Note 1)
|
|
(53,248
|
)
|
|
(46,220
|
)
|
||
|
Additional paid-in capital
|
|
527,992
|
|
|
511,432
|
|
||
|
Retained earnings
|
|
2,394,203
|
|
|
1,954,661
|
|
||
|
Accumulated other comprehensive loss
|
|
(36,433
|
)
|
|
(2,616
|
)
|
||
|
Total Westlake Chemical Corporation stockholders' equity
|
|
2,833,861
|
|
|
2,418,603
|
|
||
|
Noncontrolling interests
|
|
288,487
|
|
|
—
|
|
||
|
Total equity
|
|
3,122,348
|
|
|
2,418,603
|
|
||
|
Total liabilities and equity
|
|
$
|
5,126,283
|
|
|
$
|
4,060,909
|
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
(in thousands of dollars, except per share data and share amounts)
|
||||||||||||||
|
Net sales
|
|
$
|
1,253,227
|
|
|
$
|
1,004,165
|
|
|
$
|
3,279,479
|
|
|
$
|
2,807,859
|
|
|
Cost of sales
|
|
891,707
|
|
|
699,694
|
|
|
2,324,978
|
|
|
2,002,092
|
|
||||
|
Gross profit
|
|
361,520
|
|
|
304,471
|
|
|
954,501
|
|
|
805,767
|
|
||||
|
Selling, general and administrative expenses
|
|
54,759
|
|
|
37,869
|
|
|
132,897
|
|
|
109,883
|
|
||||
|
Income from operations
|
|
306,761
|
|
|
266,602
|
|
|
821,604
|
|
|
695,884
|
|
||||
|
Other income (expense)
|
|
|
|
|
|
|
|
|
||||||||
|
Interest expense
|
|
(9,486
|
)
|
|
(3,297
|
)
|
|
(28,182
|
)
|
|
(14,921
|
)
|
||||
|
Other (expense) income, net
|
|
(2,670
|
)
|
|
(287
|
)
|
|
4,440
|
|
|
3,137
|
|
||||
|
Income before income taxes
|
|
294,605
|
|
|
263,018
|
|
|
797,862
|
|
|
684,100
|
|
||||
|
Provision for income taxes
|
|
124,449
|
|
|
92,728
|
|
|
300,231
|
|
|
244,647
|
|
||||
|
Net income
|
|
170,156
|
|
|
170,290
|
|
|
497,631
|
|
|
439,453
|
|
||||
|
Net income attributable to noncontrolling
interests
|
|
2,399
|
|
|
—
|
|
|
2,399
|
|
|
—
|
|
||||
|
Net income attributable to Westlake Chemical
Corporation
|
|
$
|
167,757
|
|
|
$
|
170,290
|
|
|
$
|
495,232
|
|
|
$
|
439,453
|
|
|
Earnings per common share attributable to
Westlake Chemical Corporation (Note 1):
|
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
|
$
|
1.26
|
|
|
$
|
1.28
|
|
|
$
|
3.71
|
|
|
$
|
3.29
|
|
|
Diluted
|
|
$
|
1.25
|
|
|
$
|
1.27
|
|
|
$
|
3.69
|
|
|
$
|
3.27
|
|
|
Weighted average common shares outstanding (Note 1):
|
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
|
133,299,458
|
|
|
133,257,494
|
|
|
133,199,304
|
|
|
133,256,054
|
|
||||
|
Diluted
|
|
133,846,059
|
|
|
133,811,108
|
|
|
133,743,145
|
|
|
133,806,758
|
|
||||
|
Dividends per common share (Note 1)
|
|
$
|
0.1650
|
|
|
$
|
0.1125
|
|
|
$
|
0.4170
|
|
|
$
|
0.3000
|
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
(in thousands of dollars)
|
||||||||||||||
|
Net income
|
|
$
|
170,156
|
|
|
$
|
170,290
|
|
|
$
|
497,631
|
|
|
$
|
439,453
|
|
|
Other comprehensive income (loss), net of income taxes
|
|
|
|
|
|
|
|
|
||||||||
|
Pension and other post-retirement benefits liability
|
|
|
|
|
|
|
|
|
||||||||
|
Pension and other post-retirement reserves
adjustment (excluding amortization)
|
|
(31
|
)
|
|
(489
|
)
|
|
(62
|
)
|
|
(978
|
)
|
||||
|
Amortization of benefits liability
|
|
240
|
|
|
695
|
|
|
685
|
|
|
2,004
|
|
||||
|
Income tax provision on pension and other
post-retirement benefits liability
|
|
(81
|
)
|
|
(78
|
)
|
|
(240
|
)
|
|
(394
|
)
|
||||
|
Foreign currency translation adjustments
|
|
(37,792
|
)
|
|
546
|
|
|
(37,882
|
)
|
|
(844
|
)
|
||||
|
Available-for-sale investments
|
|
|
|
|
|
|
|
|
||||||||
|
Unrealized holding gains on investments
|
|
2,129
|
|
|
205
|
|
|
6,960
|
|
|
205
|
|
||||
|
Reclassification of net realized gains to
net income
|
|
—
|
|
|
—
|
|
|
(1,212
|
)
|
|
—
|
|
||||
|
Income tax provision on available-for-sale
investments
|
|
(766
|
)
|
|
(74
|
)
|
|
(2,066
|
)
|
|
(74
|
)
|
||||
|
Other comprehensive (loss) income
|
|
(36,301
|
)
|
|
805
|
|
|
(33,817
|
)
|
|
(81
|
)
|
||||
|
Comprehensive income
|
|
133,855
|
|
|
171,095
|
|
|
463,814
|
|
|
439,372
|
|
||||
|
Comprehensive income attributable to
noncontrolling interests, net of tax
|
|
2,399
|
|
|
—
|
|
|
2,399
|
|
|
—
|
|
||||
|
Comprehensive income attributable to
Westlake Chemical Corporation
|
|
$
|
131,456
|
|
|
$
|
171,095
|
|
|
$
|
461,415
|
|
|
$
|
439,372
|
|
|
|
|
Common Stock
|
|
Common Stock,
Held in Treasury
|
|
|
|
|
|
Accumulated Other Comprehensive
Income (Loss)
|
|
|
|
|
||||||||||||||||||||||||||||
|
|
|
Number of
Shares
|
|
Amount
|
|
Number of
Shares
|
|
At Cost
|
|
Additional
Paid-in
Capital
|
|
Retained
Earnings
|
|
Benefits
Liability,
Net of Tax
|
|
Cumulative
Foreign
Currency
Exchange
|
|
Net
Unrealized
Holding
Gains on
Investments,
Net of Tax
|
|
Noncontrolling Interests
|
|
Total
|
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
|
|
(in thousands of dollars, except share amounts)
|
||||||||||||||||||||||||||||||||||||||||
|
Balances at December 31, 2012
|
|
134,374,448
|
|
|
$
|
1,345
|
|
|
568,986
|
|
|
$
|
(13,302
|
)
|
|
$
|
495,581
|
|
|
$
|
1,399,472
|
|
|
$
|
(16,351
|
)
|
|
$
|
5,511
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,872,256
|
|
|
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
610,425
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
610,425
|
|
|||||||||
|
Other comprehensive
(loss) income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
9,655
|
|
|
(1,607
|
)
|
|
176
|
|
|
—
|
|
|
8,224
|
|
|||||||||
|
Common stock
repurchased
|
|
—
|
|
|
—
|
|
|
683,936
|
|
|
(32,918
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(32,918
|
)
|
|||||||||
|
Shares issued - stock-
based compensation
|
|
225,924
|
|
|
1
|
|
|
—
|
|
|
—
|
|
|
3,436
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3,437
|
|
|||||||||
|
Stock-based
compensation, net of
tax on stock options
exercised
|
|
(20,164
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
12,415
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
12,415
|
|
|||||||||
|
Dividends paid
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(55,236
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(55,236
|
)
|
|||||||||
|
Balances at December 31, 2013
|
|
134,580,208
|
|
|
1,346
|
|
|
1,252,922
|
|
|
(46,220
|
)
|
|
511,432
|
|
|
1,954,661
|
|
|
(6,696
|
)
|
|
3,904
|
|
|
176
|
|
|
—
|
|
|
2,418,603
|
|
|||||||||
|
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
495,232
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,399
|
|
|
497,631
|
|
|||||||||
|
Other comprehensive
income (loss)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
383
|
|
|
(37,882
|
)
|
|
3,682
|
|
|
—
|
|
|
(33,817
|
)
|
|||||||||
|
Common stock
repurchased
|
|
—
|
|
|
—
|
|
|
104,163
|
|
|
(9,495
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(9,495
|
)
|
|||||||||
|
Shares issued - stock-
based compensation
|
|
124,566
|
|
|
1
|
|
|
(136,541
|
)
|
|
2,467
|
|
|
3,034
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,502
|
|
|||||||||
|
Stock-based
compensation, net of
tax on stock options
exercised
|
|
(24,610
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
13,526
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
13,526
|
|
|||||||||
|
Dividends paid
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
(55,690
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(55,690
|
)
|
||||||||||
|
Issuance of Westlake
Chemical Partners LP
common units
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
286,088
|
|
|
286,088
|
|
||||||||||
|
Balances at September 30, 2014
|
|
134,680,164
|
|
|
$
|
1,347
|
|
|
1,220,544
|
|
|
$
|
(53,248
|
)
|
|
$
|
527,992
|
|
|
$
|
2,394,203
|
|
|
$
|
(6,313
|
)
|
|
$
|
(33,978
|
)
|
|
$
|
3,858
|
|
|
$
|
288,487
|
|
|
$
|
3,122,348
|
|
|
|
|
Nine Months Ended September 30,
|
||||||
|
|
|
2014
|
|
2013
|
||||
|
|
|
|
|
|
||||
|
|
|
(in thousands of dollars)
|
||||||
|
Cash flows from operating activities
|
|
|
|
|
||||
|
Net income
|
|
$
|
497,631
|
|
|
$
|
439,453
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities
|
|
|
|
|
||||
|
Depreciation and amortization
|
|
148,394
|
|
|
116,294
|
|
||
|
Provision for doubtful accounts
|
|
295
|
|
|
3,600
|
|
||
|
Amortization of debt issuance costs
|
|
1,172
|
|
|
1,093
|
|
||
|
Stock-based compensation expense
|
|
6,856
|
|
|
4,804
|
|
||
|
Loss from disposition of fixed assets
|
|
2,635
|
|
|
4,679
|
|
||
|
Deferred income taxes
|
|
34,459
|
|
|
83,443
|
|
||
|
Windfall tax benefits from share-based payment arrangements
|
|
(6,670
|
)
|
|
(5,056
|
)
|
||
|
(Income) loss from equity method investments, net of dividends
|
|
(3,199
|
)
|
|
1,586
|
|
||
|
Other gains, net
|
|
(495
|
)
|
|
—
|
|
||
|
Changes in operating assets and liabilities
|
|
|
|
|
||||
|
Accounts receivable
|
|
6,055
|
|
|
(18,874
|
)
|
||
|
Inventories
|
|
80,492
|
|
|
(26,325
|
)
|
||
|
Prepaid expenses and other current assets
|
|
458
|
|
|
(5,038
|
)
|
||
|
Accounts payable
|
|
(98,769
|
)
|
|
19,518
|
|
||
|
Accrued liabilities
|
|
111,965
|
|
|
(15,755
|
)
|
||
|
Other, net
|
|
(5,155
|
)
|
|
(55,922
|
)
|
||
|
Net cash provided by operating activities
|
|
776,124
|
|
|
547,500
|
|
||
|
Cash flows from investing activities
|
|
|
|
|
||||
|
Acquisition of business, net of cash acquired
|
|
(611,087
|
)
|
|
(178,309
|
)
|
||
|
Additions to equity investments
|
|
—
|
|
|
(23,338
|
)
|
||
|
Additions to property, plant and equipment
|
|
(311,183
|
)
|
|
(498,290
|
)
|
||
|
Construction of assets pending sale-leaseback
|
|
—
|
|
|
(136
|
)
|
||
|
Proceeds from disposition of assets
|
|
145
|
|
|
78
|
|
||
|
Proceeds from repayment of loan acquired
|
|
45,923
|
|
|
—
|
|
||
|
Proceeds from repayment of loan to affiliate
|
|
—
|
|
|
167
|
|
||
|
Proceeds from sales and maturities of securities
|
|
342,045
|
|
|
239,764
|
|
||
|
Purchase of securities
|
|
(117,332
|
)
|
|
(232,286
|
)
|
||
|
Settlements of derivative instruments
|
|
(689
|
)
|
|
(2,297
|
)
|
||
|
Net cash used for investing activities
|
|
(652,178
|
)
|
|
(694,647
|
)
|
||
|
Cash flows from financing activities
|
|
|
|
|
||||
|
Capitalized debt issuance costs
|
|
(1,167
|
)
|
|
—
|
|
||
|
Dividends paid
|
|
(55,690
|
)
|
|
(40,204
|
)
|
||
|
Net proceeds from issuance of Westlake Chemical Partners LP common units
|
|
286,088
|
|
|
—
|
|
||
|
Proceeds from exercise of stock options
|
|
5,502
|
|
|
3,182
|
|
||
|
Repurchase of common stock for treasury
|
|
(9,495
|
)
|
|
(19,409
|
)
|
||
|
Windfall tax benefits from share-based payment arrangements
|
|
6,670
|
|
|
5,056
|
|
||
|
Net cash provided by (used for) financing activities
|
|
231,908
|
|
|
(51,375
|
)
|
||
|
Effect of exchange rate changes on cash and cash equivalents
|
|
(3,687
|
)
|
|
—
|
|
||
|
Net increase (decrease) in cash and cash equivalents
|
|
352,167
|
|
|
(198,522
|
)
|
||
|
Cash and cash equivalents at beginning of period
|
|
461,301
|
|
|
790,078
|
|
||
|
Cash and cash equivalents at end of period
|
|
$
|
813,468
|
|
|
$
|
591,556
|
|
|
|
September 30,
2014 |
|
December 31,
2013 |
||||
|
Current
|
$
|
—
|
|
|
$
|
239,388
|
|
|
Non-current
|
21,066
|
|
|
—
|
|
||
|
Total available-for-sale securities
|
$
|
21,066
|
|
|
$
|
239,388
|
|
|
|
|
September 30, 2014
|
||||||||||||||
|
|
|
Cost
|
|
Gross
Unrealized Gains |
|
Gross
Unrealized Losses |
|
Fair Value
|
||||||||
|
Equity securities
|
|
$
|
15,044
|
|
|
$
|
6,022
|
|
|
$
|
—
|
|
|
$
|
21,066
|
|
|
Total available-for-sale securities
|
|
$
|
15,044
|
|
|
$
|
6,022
|
|
|
$
|
—
|
|
|
$
|
21,066
|
|
|
|
|
December 31, 2013
|
||||||||||||||
|
|
|
Cost
|
|
Gross
Unrealized Gains |
|
Gross
Unrealized Losses (1) |
|
Fair Value
|
||||||||
|
Debt securities
|
|
|
|
|
|
|
|
|
||||||||
|
Corporate bonds
|
|
$
|
108,300
|
|
|
$
|
340
|
|
|
$
|
(69
|
)
|
|
$
|
108,571
|
|
|
U.S. government debt
(2)
|
|
106,335
|
|
|
60
|
|
|
(79
|
)
|
|
106,316
|
|
||||
|
Asset-backed securities
|
|
24,478
|
|
|
34
|
|
|
(11
|
)
|
|
24,501
|
|
||||
|
Total available-for-sale securities
|
|
$
|
239,113
|
|
|
$
|
434
|
|
|
$
|
(159
|
)
|
|
$
|
239,388
|
|
|
(1)
|
All unrealized loss positions were held at a loss for less than 12 months.
|
|
(2)
|
U.S. Treasury obligations, U.S. government agency obligations and U.S government agency mortgage-backed securities.
|
|
|
|
Nine Months Ended September 30,
|
||
|
|
|
2014
|
||
|
Proceeds from sales and maturities of securities
|
|
$
|
342,045
|
|
|
Gross realized gains
|
|
$
|
1,311
|
|
|
Gross realized losses
|
|
$
|
(99
|
)
|
|
|
|
September 30,
2014 |
|
December 31,
2013 |
||||
|
Trade customers
|
|
$
|
576,735
|
|
|
$
|
410,302
|
|
|
Affiliates
|
|
631
|
|
|
315
|
|
||
|
Allowance for doubtful accounts
|
|
(13,772
|
)
|
|
(11,741
|
)
|
||
|
|
|
563,594
|
|
|
398,876
|
|
||
|
Federal and state taxes
|
|
5,374
|
|
|
20,820
|
|
||
|
Other
|
|
23,996
|
|
|
8,761
|
|
||
|
Accounts receivable, net
|
|
$
|
592,964
|
|
|
$
|
428,457
|
|
|
|
|
September 30,
2014 |
|
December 31,
2013 |
||||
|
Finished products
|
|
$
|
268,969
|
|
|
$
|
232,658
|
|
|
Feedstock, additives and chemicals
|
|
166,268
|
|
|
180,646
|
|
||
|
Materials and supplies
|
|
65,315
|
|
|
58,575
|
|
||
|
Inventories
|
|
$
|
500,552
|
|
|
$
|
471,879
|
|
|
|
|
September 30,
2014 |
|
December 31,
2013 |
||||
|
3.60% senior notes due 2022
|
|
$
|
249,079
|
|
|
$
|
248,990
|
|
|
6 ½% senior notes due 2029
|
|
100,000
|
|
|
100,000
|
|
||
|
6 ¾% senior notes due 2032
|
|
250,000
|
|
|
250,000
|
|
||
|
6 ½% senior notes due 2035 (the "6 ½% GO Zone Senior Notes Due 2035")
|
|
89,000
|
|
|
89,000
|
|
||
|
6 ½% senior notes due 2035 (the "6 ½% IKE Zone Senior Notes Due 2035")
|
|
65,000
|
|
|
65,000
|
|
||
|
Loan related to tax-exempt waste disposal revenue bonds due 2027
|
|
10,889
|
|
|
10,889
|
|
||
|
Long-term debt, net
|
|
$
|
763,968
|
|
|
$
|
763,879
|
|
|
|
|
Derivative Assets
|
||||||||
|
|
|
Balance Sheet Location
|
|
Fair Value as of
|
||||||
|
|
|
September 30,
2014 |
|
December 31,
2013 |
||||||
|
Not designated as hedging instruments
|
|
|
|
|
|
|
||||
|
Commodity forward contracts
|
|
Accounts receivable, net
|
|
$
|
451
|
|
|
$
|
296
|
|
|
Total derivative assets
|
|
|
|
$
|
451
|
|
|
$
|
296
|
|
|
|
|
Derivative Liabilities
|
||||||||
|
|
|
Balance Sheet Location
|
|
Fair Value as of
|
||||||
|
|
|
September 30,
2014 |
|
December 31,
2013 |
||||||
|
Not designated as hedging instruments
|
|
|
|
|
|
|
||||
|
Commodity forward contracts
|
|
Accrued liabilities
|
|
$
|
6,477
|
|
|
$
|
176
|
|
|
Total derivative liabilities
|
|
|
|
$
|
6,477
|
|
|
$
|
176
|
|
|
Derivatives in Fair Value
Hedging Relationships
|
|
Location of Gain (Loss)
Recognized in
Income on Derivative
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||||||
|
Commodity forward contracts
|
|
Cost of sales
|
|
$
|
—
|
|
|
$
|
(232
|
)
|
|
$
|
—
|
|
|
$
|
(342
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Hedged Items in Fair Value
Hedging Relationships
|
|
Location of Gain (Loss)
Recognized in
Income on Hedged Items
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||||||
|
Firm commitment designated
as the hedged item
|
|
Cost of sales
|
|
$
|
—
|
|
|
$
|
236
|
|
|
$
|
—
|
|
|
$
|
15
|
|
|
Derivatives Not Designated as
Hedging Instruments
|
|
Location of Gain (Loss)
Recognized in
Income on Derivative
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||||||
|
Commodity forward contracts
|
|
Gross profit
|
|
$
|
(6,937
|
)
|
|
$
|
4,854
|
|
|
$
|
(7,308
|
)
|
|
$
|
9,897
|
|
|
|
|
September 30, 2014
|
||||||||||
|
|
|
Level 1
|
|
Level 2
|
|
Total
|
||||||
|
Derivative instruments
|
|
|
|
|
|
|
||||||
|
Risk management assets - Commodity forward contracts
|
|
$
|
428
|
|
|
$
|
23
|
|
|
$
|
451
|
|
|
Risk management liabilities - Commodity forward contracts
|
|
(119
|
)
|
|
(6,358
|
)
|
|
(6,477
|
)
|
|||
|
Available-for-sale marketable securities
|
|
21,066
|
|
|
—
|
|
|
21,066
|
|
|||
|
|
|
|
|
|
|
|
||||||
|
|
|
December 31, 2013
|
||||||||||
|
|
|
Level 1
|
|
Level 2
|
|
Total
|
||||||
|
Derivative instruments
|
|
|
|
|
|
|
||||||
|
Risk management assets - Commodity forward contracts
|
|
$
|
48
|
|
|
$
|
248
|
|
|
$
|
296
|
|
|
Risk management liabilities - Commodity forward contracts
|
|
—
|
|
|
(176
|
)
|
|
(176
|
)
|
|||
|
Available-for-sale marketable securities
|
|
91,595
|
|
|
147,793
|
|
|
239,388
|
|
|||
|
|
|
September 30, 2014
|
|
December 31, 2013
|
||||||||||||
|
|
|
Carrying
Value
|
|
Fair
Value
|
|
Carrying
Value
|
|
Fair
Value
|
||||||||
|
3.60% senior notes due 2022
|
|
$
|
249,079
|
|
|
$
|
247,633
|
|
|
$
|
248,990
|
|
|
$
|
236,905
|
|
|
6 ½% senior notes due 2029
|
|
100,000
|
|
|
114,624
|
|
|
100,000
|
|
|
109,490
|
|
||||
|
6 ¾% senior notes due 2032
|
|
250,000
|
|
|
275,313
|
|
|
250,000
|
|
|
265,148
|
|
||||
|
6 ½% GO Zone Senior Notes Due 2035
|
|
89,000
|
|
|
101,855
|
|
|
89,000
|
|
|
94,606
|
|
||||
|
6 ½% IKE Zone Senior Notes Due 2035
|
|
65,000
|
|
|
74,389
|
|
|
65,000
|
|
|
69,094
|
|
||||
|
Loan related to tax-exempt waste disposal revenue
bonds due 2027
|
|
10,889
|
|
|
10,889
|
|
|
10,889
|
|
|
10,889
|
|
||||
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
|
Net income attributable to Westlake Chemical
Corporation
|
|
$
|
167,757
|
|
|
$
|
170,290
|
|
|
$
|
495,232
|
|
|
$
|
439,453
|
|
|
Less:
|
|
|
|
|
|
|
|
|
||||||||
|
Net income attributable to participating securities
|
|
(353
|
)
|
|
(587
|
)
|
|
(1,099
|
)
|
|
(1,691
|
)
|
||||
|
Net income attributable to common shareholders
|
|
$
|
167,404
|
|
|
$
|
169,703
|
|
|
$
|
494,133
|
|
|
$
|
437,762
|
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
|
Weighted average common shares—basic
(1)
|
|
133,299,458
|
|
|
133,257,494
|
|
|
133,199,304
|
|
|
133,256,054
|
|
||||
|
Plus incremental shares from:
|
|
|
|
|
|
|
|
|
||||||||
|
Assumed exercise of options
(1)
|
|
546,601
|
|
|
553,614
|
|
|
543,841
|
|
|
550,704
|
|
||||
|
Weighted average common shares—diluted
(1)
|
|
133,846,059
|
|
|
133,811,108
|
|
|
133,743,145
|
|
|
133,806,758
|
|
||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
Earnings per common share attributable to
Westlake Chemical Corporation :
(1)
|
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
|
$
|
1.26
|
|
|
$
|
1.28
|
|
|
$
|
3.71
|
|
|
$
|
3.29
|
|
|
Diluted
|
|
$
|
1.25
|
|
|
$
|
1.27
|
|
|
$
|
3.69
|
|
|
$
|
3.27
|
|
|
(1)
|
Share amounts and per share data for the three and
nine months ended September 30, 2013
have been restated to reflect the effect of a
two
-for-one stock split on March 18, 2014. See Note 1 for additional information.
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||||||||||||||||||
|
|
|
Pension
|
|
Post-retirement
Healthcare
|
|
Pension
|
|
Post-retirement
Healthcare
|
||||||||||||||||||||||||
|
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||||||||||
|
Service cost
|
|
$
|
331
|
|
|
$
|
275
|
|
|
$
|
6
|
|
|
$
|
2
|
|
|
$
|
498
|
|
|
$
|
815
|
|
|
$
|
16
|
|
|
$
|
7
|
|
|
Interest cost
|
|
1,138
|
|
|
515
|
|
|
185
|
|
|
147
|
|
|
2,309
|
|
|
1,531
|
|
|
548
|
|
|
442
|
|
||||||||
|
Expected return on
plan assets
|
|
(777
|
)
|
|
(713
|
)
|
|
—
|
|
|
—
|
|
|
(2,363
|
)
|
|
(2,140
|
)
|
|
—
|
|
|
—
|
|
||||||||
|
Amortization of prior
service cost
|
|
74
|
|
|
74
|
|
|
13
|
|
|
21
|
|
|
223
|
|
|
223
|
|
|
38
|
|
|
63
|
|
||||||||
|
Amortization of net loss
|
|
71
|
|
|
510
|
|
|
82
|
|
|
90
|
|
|
204
|
|
|
1,449
|
|
|
220
|
|
|
269
|
|
||||||||
|
Net periodic benefit cost
|
|
$
|
837
|
|
|
$
|
661
|
|
|
$
|
286
|
|
|
$
|
260
|
|
|
$
|
871
|
|
|
$
|
1,878
|
|
|
$
|
822
|
|
|
$
|
781
|
|
|
|
|
Benefits
Liability,
Net of Tax
|
|
Cumulative
Foreign
Currency
Exchange
|
|
Net Unrealized
Holding Gains
on Investments,
Net of Tax
|
|
Total
|
||||||||
|
Balances at December 31, 2013
|
|
$
|
(6,696
|
)
|
|
$
|
3,904
|
|
|
$
|
176
|
|
|
$
|
(2,616
|
)
|
|
Other comprehensive (loss) income before
reclassifications
|
|
(39
|
)
|
|
(37,882
|
)
|
|
4,459
|
|
|
(33,462
|
)
|
||||
|
Amounts reclassified from accumulated other
comprehensive loss
|
|
422
|
|
|
—
|
|
|
(777
|
)
|
|
(355
|
)
|
||||
|
Net other comprehensive income (loss) for the period
|
|
383
|
|
|
(37,882
|
)
|
|
3,682
|
|
|
(33,817
|
)
|
||||
|
Balances at September 30, 2014
|
|
$
|
(6,313
|
)
|
|
$
|
(33,978
|
)
|
|
$
|
3,858
|
|
|
$
|
(36,433
|
)
|
|
|
|
Benefits
Liability,
Net of Tax
|
|
Cumulative
Foreign
Currency
Exchange
|
|
Net Unrealized
Holding Gains
on Investments,
Net of Tax
|
|
Total
|
||||||||
|
Balances at December 31, 2012
|
|
$
|
(16,351
|
)
|
|
$
|
5,511
|
|
|
$
|
—
|
|
|
$
|
(10,840
|
)
|
|
Other comprehensive (loss) income before
reclassifications
|
|
(601
|
)
|
|
(844
|
)
|
|
131
|
|
|
(1,314
|
)
|
||||
|
Amounts reclassified from accumulated other
comprehensive loss
|
|
1,233
|
|
|
—
|
|
|
—
|
|
|
1,233
|
|
||||
|
Net other comprehensive income (loss) for the period
|
|
632
|
|
|
(844
|
)
|
|
131
|
|
|
(81
|
)
|
||||
|
Balances at September 30, 2013
|
|
$
|
(15,719
|
)
|
|
$
|
4,667
|
|
|
$
|
131
|
|
|
$
|
(10,921
|
)
|
|
Details about Accumulated Other Comprehensive
Income (Loss) Components
|
|
Location of Reclassification
(Income (Expense)) in
Consolidated Statements
of Operations
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
|||||||||||
|
Amortization of pension and
other post-retirement items
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Prior service costs
|
|
(1)
|
|
$
|
(87
|
)
|
|
$
|
(95
|
)
|
|
$
|
(261
|
)
|
|
$
|
(286
|
)
|
|
Net loss
|
|
(1)
|
|
(153
|
)
|
|
(600
|
)
|
|
(424
|
)
|
|
(1,718
|
)
|
||||
|
|
|
|
|
(240
|
)
|
|
(695
|
)
|
|
(685
|
)
|
|
(2,004
|
)
|
||||
|
|
|
Provision for income
taxes
|
|
92
|
|
|
267
|
|
|
263
|
|
|
771
|
|
||||
|
|
|
|
|
(148
|
)
|
|
(428
|
)
|
|
(422
|
)
|
|
(1,233
|
)
|
||||
|
Net unrealized gains on
available-for-sale
investments
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Realized gain on
available-for-sale
investments
|
|
Other income, net
|
|
—
|
|
|
—
|
|
|
1,212
|
|
|
—
|
|
||||
|
|
|
Provision for income
taxes
|
|
—
|
|
|
—
|
|
|
(435
|
)
|
|
—
|
|
||||
|
|
|
|
|
—
|
|
|
—
|
|
|
$
|
777
|
|
|
$
|
—
|
|
||
|
Total reclassifications for
the period
|
|
|
|
$
|
(148
|
)
|
|
$
|
(428
|
)
|
|
$
|
355
|
|
|
$
|
(1,233
|
)
|
|
(1)
|
These accumulated other comprehensive loss components are included in the computation of net periodic benefit cost. For additional information, please read Note 10 (Employee Benefits) to the financial statements included in the
2013
Form 10-K.
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
|
Net external sales
|
|
|
|
|
|
|
|
|
||||||||
|
Olefins
|
|
|
|
|
|
|
|
|
||||||||
|
Polyethylene
|
|
$
|
498,450
|
|
|
$
|
460,105
|
|
|
$
|
1,461,097
|
|
|
$
|
1,294,566
|
|
|
Styrene, feedstock and other
|
|
204,647
|
|
|
219,234
|
|
|
663,851
|
|
|
590,959
|
|
||||
|
Total Olefins
|
|
703,097
|
|
|
679,339
|
|
|
2,124,948
|
|
|
1,885,525
|
|
||||
|
Vinyls
|
|
|
|
|
|
|
|
|
||||||||
|
PVC, caustic soda and other
|
|
416,771
|
|
|
212,041
|
|
|
776,060
|
|
|
612,391
|
|
||||
|
Building products
|
|
133,359
|
|
|
112,785
|
|
|
378,471
|
|
|
309,943
|
|
||||
|
Total Vinyls
|
|
550,130
|
|
|
324,826
|
|
|
1,154,531
|
|
|
922,334
|
|
||||
|
|
|
$
|
1,253,227
|
|
|
$
|
1,004,165
|
|
|
$
|
3,279,479
|
|
|
$
|
2,807,859
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Intersegment sales
|
|
|
|
|
|
|
|
|
||||||||
|
Olefins
|
|
$
|
26,518
|
|
|
$
|
85,454
|
|
|
$
|
118,153
|
|
|
$
|
230,607
|
|
|
Vinyls
|
|
355
|
|
|
403
|
|
|
1,029
|
|
|
1,111
|
|
||||
|
|
|
$
|
26,873
|
|
|
$
|
85,857
|
|
|
$
|
119,182
|
|
|
$
|
231,718
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Income (loss) from operations
|
|
|
|
|
|
|
|
|
||||||||
|
Olefins
|
|
$
|
259,277
|
|
|
$
|
237,239
|
|
|
$
|
770,267
|
|
|
$
|
585,958
|
|
|
Vinyls
|
|
59,445
|
|
|
39,554
|
|
|
76,460
|
|
|
136,123
|
|
||||
|
Corporate and other
|
|
(11,961
|
)
|
|
(10,191
|
)
|
|
(25,123
|
)
|
|
(26,197
|
)
|
||||
|
|
|
$
|
306,761
|
|
|
$
|
266,602
|
|
|
$
|
821,604
|
|
|
$
|
695,884
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Depreciation and amortization
|
|
|
|
|
|
|
|
|
||||||||
|
Olefins
|
|
$
|
26,443
|
|
|
$
|
26,515
|
|
|
$
|
79,811
|
|
|
$
|
76,415
|
|
|
Vinyls
|
|
27,336
|
|
|
14,089
|
|
|
68,127
|
|
|
39,507
|
|
||||
|
Corporate and other
|
|
141
|
|
|
124
|
|
|
456
|
|
|
372
|
|
||||
|
|
|
$
|
53,920
|
|
|
$
|
40,728
|
|
|
$
|
148,394
|
|
|
$
|
116,294
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Other income (expense), net
|
|
|
|
|
|
|
|
|
||||||||
|
Olefins
|
|
$
|
1,609
|
|
|
$
|
728
|
|
|
$
|
4,262
|
|
|
$
|
5,889
|
|
|
Vinyls
|
|
1,189
|
|
|
(742
|
)
|
|
942
|
|
|
(1,687
|
)
|
||||
|
Corporate and other
|
|
(5,468
|
)
|
|
(273
|
)
|
|
(764
|
)
|
|
(1,065
|
)
|
||||
|
|
|
$
|
(2,670
|
)
|
|
$
|
(287
|
)
|
|
$
|
4,440
|
|
|
$
|
3,137
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Provision for (benefit from) income taxes
|
|
|
|
|
|
|
|
|
||||||||
|
Olefins
|
|
$
|
105,030
|
|
|
$
|
82,553
|
|
|
$
|
282,082
|
|
|
$
|
208,170
|
|
|
Vinyls
|
|
21,761
|
|
|
10,710
|
|
|
22,121
|
|
|
44,120
|
|
||||
|
Corporate and other
|
|
(2,342
|
)
|
|
(535
|
)
|
|
(3,972
|
)
|
|
(7,643
|
)
|
||||
|
|
|
$
|
124,449
|
|
|
$
|
92,728
|
|
|
$
|
300,231
|
|
|
$
|
244,647
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Capital expenditures
|
|
|
|
|
|
|
|
|
||||||||
|
Olefins
|
|
$
|
48,519
|
|
|
$
|
27,577
|
|
|
$
|
121,041
|
|
|
$
|
105,656
|
|
|
Vinyls
|
|
44,067
|
|
|
172,565
|
|
|
187,449
|
|
|
391,864
|
|
||||
|
Corporate and other
|
|
1,685
|
|
|
276
|
|
|
2,693
|
|
|
770
|
|
||||
|
|
|
$
|
94,271
|
|
|
$
|
200,418
|
|
|
$
|
311,183
|
|
|
$
|
498,290
|
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
|
Income from operations
|
|
$
|
306,761
|
|
|
$
|
266,602
|
|
|
$
|
821,604
|
|
|
$
|
695,884
|
|
|
Interest expense
|
|
(9,486
|
)
|
|
(3,297
|
)
|
|
(28,182
|
)
|
|
(14,921
|
)
|
||||
|
Other (expense) income, net
|
|
(2,670
|
)
|
|
(287
|
)
|
|
4,440
|
|
|
3,137
|
|
||||
|
Income before income taxes
|
|
$
|
294,605
|
|
|
$
|
263,018
|
|
|
$
|
797,862
|
|
|
$
|
684,100
|
|
|
|
|
September 30,
2014 |
|
December 31,
2013 |
||||
|
Total assets
|
|
|
|
|
||||
|
Olefins
|
|
$
|
1,740,878
|
|
|
$
|
1,557,510
|
|
|
Vinyls
|
|
2,898,250
|
|
|
1,740,595
|
|
||
|
Corporate and other
|
|
487,155
|
|
|
762,804
|
|
||
|
|
|
$
|
5,126,283
|
|
|
$
|
4,060,909
|
|
|
Total proceeds from the initial public offering
|
|
$
|
310,500
|
|
|
Less: Offering Costs
|
|
(24,412
|
)
|
|
|
Net proceeds from the initial public offering
|
|
286,088
|
|
|
|
Less: Cash retained by OpCo
|
|
(55,419
|
)
|
|
|
Net proceeds distributed to the Company from the initial public offering
|
|
$
|
230,669
|
|
|
|
|
Pro Forma
Nine Months Ended
September 30,
|
||||||
|
|
|
2014
|
|
2013
|
||||
|
Net sales
|
|
$
|
4,016,935
|
|
|
$
|
3,747,619
|
|
|
Net income
|
|
$
|
550,667
|
|
|
$
|
480,964
|
|
|
Net income attributable to noncontrolling interests
|
|
2,399
|
|
|
—
|
|
||
|
Net income attributable to Westlake Chemical Corporation
|
|
$
|
548,268
|
|
|
$
|
480,964
|
|
|
Earnings per common share attributable to Westlake Chemical Corporation:
|
|
|
|
|
||||
|
Basic
|
|
$
|
4.11
|
|
|
$
|
3.59
|
|
|
Diluted
|
|
$
|
4.09
|
|
|
$
|
3.58
|
|
|
Fair value of consideration transferred:
|
|
|
||
|
Cash paid to Sellers
|
|
$
|
309,619
|
|
|
Cash deposited in escrow
(1)
|
|
13,390
|
|
|
|
Retirement of long-term debt as of July 31, 2014, on behalf of the Sellers
(2)
|
|
413,215
|
|
|
|
Total purchase consideration
|
|
$
|
736,224
|
|
|
|
|
|
||
|
Preliminary allocation of consideration transferred to net assets acquired:
|
|
|
||
|
Cash
|
|
$
|
125,137
|
|
|
Working capital, excluding inventory and cash
(3)
|
|
23,072
|
|
|
|
Inventories
(4)
|
|
114,961
|
|
|
|
Property, plant and equipment
|
|
471,123
|
|
|
|
Investments
|
|
51,552
|
|
|
|
Other assets
(5)
|
|
65,366
|
|
|
|
Intangible assets:
|
|
|
||
|
Trademarks and trade name (weighted average life of 20 years)
|
|
40,170
|
|
|
|
Developed technologies (weighted average life of 20 years)
|
|
31,600
|
|
|
|
Other intangibles (weighted average life of 9.4 years)
|
|
1,422
|
|
|
|
Deferred income tax asset - current
|
|
8,697
|
|
|
|
Deferred income tax asset - non-current
|
|
27,387
|
|
|
|
Pension obligation
|
|
(117,970
|
)
|
|
|
Other long-term liabilities
|
|
(10,723
|
)
|
|
|
Power purchase agreement liability
(6)
|
|
(10,826
|
)
|
|
|
Deferred income tax liability - current
|
|
(6,845
|
)
|
|
|
Deferred income tax liability - non-current
|
|
(77,899
|
)
|
|
|
Total identifiable net assets
|
|
736,224
|
|
|
|
Goodwill
(7)
|
|
—
|
|
|
|
Consideration transferred
|
|
$
|
736,224
|
|
|
(1)
|
None of the cash held in escrow is considered contingent consideration as it is expected to be released to the Sellers pending the Sellers’ satisfaction of general representations and warranties made in connection with the execution of the purchase agreement.
|
|
(2)
|
Vinnolit’s long-term debt paid on behalf of the Sellers was not legally assumed by Westlake in the acquisition and was a condition of the consummation of the purchase agreement. Therefore, the retirement has been included in the total purchase consideration.
|
|
(3)
|
The fair value of accounts receivable acquired is
$181,826
, with the gross contractual amount being
$183,769
. The Company expects
$1,943
to be uncollectible.
|
|
(4)
|
An adjustment of approximately
$16,900
was recorded to reflect Vinnolit's inventories at fair value and increased cost of sales by the same amount for the
three months ended September 30, 2014
.
|
|
(5)
|
Included in other assets was a loan acquired that was repaid prior to September 30, 2014.
|
|
(6)
|
A liability arising from unfavorable forward purchase contracts for the purchase of power was recognized at fair value. This liability will be amortized over a period of approximately
3.0
years, being the weighted-average life of the forward purchase contracts.
|
|
(7)
|
Management estimated that the fair value of the net assets acquired equals consideration paid. Therefore, no goodwill was recorded.
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
|
Balance Sheet
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Current assets
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Cash and cash equivalents
|
|
$
|
652,709
|
|
|
$
|
1,644
|
|
|
$
|
89,144
|
|
|
$
|
69,971
|
|
|
$
|
—
|
|
|
$
|
813,468
|
|
|
Accounts receivable, net
|
|
15,064
|
|
|
1,377,250
|
|
|
58,106
|
|
|
170,833
|
|
|
(1,028,289
|
)
|
|
592,964
|
|
||||||
|
Inventories
|
|
—
|
|
|
385,826
|
|
|
5,551
|
|
|
109,175
|
|
|
—
|
|
|
500,552
|
|
||||||
|
Prepaid expenses and other current assets
|
|
137
|
|
|
14,737
|
|
|
303
|
|
|
3,707
|
|
|
—
|
|
|
18,884
|
|
||||||
|
Deferred income taxes
|
|
342
|
|
|
25,446
|
|
|
—
|
|
|
292
|
|
|
—
|
|
|
26,080
|
|
||||||
|
Total current assets
|
|
668,252
|
|
|
1,804,903
|
|
|
153,104
|
|
|
353,978
|
|
|
(1,028,289
|
)
|
|
1,951,948
|
|
||||||
|
Property, plant and equipment, net
|
|
—
|
|
|
1,451,807
|
|
|
806,648
|
|
|
452,020
|
|
|
—
|
|
|
2,710,475
|
|
||||||
|
Equity investments
|
|
3,878,703
|
|
|
1,207,569
|
|
|
—
|
|
|
356,286
|
|
|
(5,371,730
|
)
|
|
70,828
|
|
||||||
|
Other assets, net
|
|
34,847
|
|
|
351,271
|
|
|
61,679
|
|
|
137,990
|
|
|
(192,755
|
)
|
|
393,032
|
|
||||||
|
Total assets
|
|
$
|
4,581,802
|
|
|
$
|
4,815,550
|
|
|
$
|
1,021,431
|
|
|
$
|
1,300,274
|
|
|
$
|
(6,592,774
|
)
|
|
$
|
5,126,283
|
|
|
Current liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Accounts payable
|
|
$
|
979,414
|
|
|
$
|
157,562
|
|
|
$
|
29,856
|
|
|
$
|
100,129
|
|
|
$
|
(1,003,596
|
)
|
|
$
|
263,365
|
|
|
Accrued liabilities
|
|
15,448
|
|
|
238,225
|
|
|
3,412
|
|
|
77,279
|
|
|
(24,693
|
)
|
|
309,671
|
|
||||||
|
Total current liabilities
|
|
994,862
|
|
|
395,787
|
|
|
33,268
|
|
|
177,408
|
|
|
(1,028,289
|
)
|
|
573,036
|
|
||||||
|
Long-term debt
|
|
753,079
|
|
|
10,889
|
|
|
188,523
|
|
|
—
|
|
|
(188,523
|
)
|
|
763,968
|
|
||||||
|
Deferred income taxes
|
|
—
|
|
|
473,343
|
|
|
1,507
|
|
|
43,155
|
|
|
(4,232
|
)
|
|
513,773
|
|
||||||
|
Other liabilities
|
|
—
|
|
|
31,616
|
|
|
—
|
|
|
121,542
|
|
|
—
|
|
|
153,158
|
|
||||||
|
Total liabilities
|
|
1,747,941
|
|
|
911,635
|
|
|
223,298
|
|
|
342,105
|
|
|
(1,221,044
|
)
|
|
2,003,935
|
|
||||||
|
Total Westlake Chemical Corporation stockholders' equity
|
|
2,833,861
|
|
|
3,903,915
|
|
|
798,133
|
|
|
669,682
|
|
|
(5,371,730
|
)
|
|
2,833,861
|
|
||||||
|
Noncontrolling interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
288,487
|
|
|
—
|
|
|
288,487
|
|
||||||
|
Total equity
|
|
2,833,861
|
|
|
3,903,915
|
|
|
798,133
|
|
|
958,169
|
|
|
(5,371,730
|
)
|
|
3,122,348
|
|
||||||
|
Total liabilities and equity
|
|
$
|
4,581,802
|
|
|
$
|
4,815,550
|
|
|
$
|
1,021,431
|
|
|
$
|
1,300,274
|
|
|
$
|
(6,592,774
|
)
|
|
$
|
5,126,283
|
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
|
Balance Sheet
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Current assets
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Cash and cash equivalents
|
|
$
|
420,948
|
|
|
$
|
6,227
|
|
|
$
|
—
|
|
|
$
|
34,126
|
|
|
$
|
—
|
|
|
$
|
461,301
|
|
|
Marketable securities
|
|
239,388
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
239,388
|
|
||||||
|
Accounts receivable, net
|
|
3,879
|
|
|
666,344
|
|
|
71,812
|
|
|
2,755
|
|
|
(316,333
|
)
|
|
428,457
|
|
||||||
|
Inventories
|
|
—
|
|
|
339,929
|
|
|
116,377
|
|
|
15,573
|
|
|
—
|
|
|
471,879
|
|
||||||
|
Prepaid expenses and other current assets
|
|
778
|
|
|
11,055
|
|
|
257
|
|
|
1,798
|
|
|
—
|
|
|
13,888
|
|
||||||
|
Deferred income taxes
|
|
441
|
|
|
28,974
|
|
|
4,448
|
|
|
306
|
|
|
—
|
|
|
34,169
|
|
||||||
|
Total current assets
|
|
665,434
|
|
|
1,052,529
|
|
|
192,894
|
|
|
54,558
|
|
|
(316,333
|
)
|
|
1,649,082
|
|
||||||
|
Property, plant and equipment, net
|
|
—
|
|
|
1,318,119
|
|
|
762,972
|
|
|
6,923
|
|
|
—
|
|
|
2,088,014
|
|
||||||
|
Equity investments
|
|
2,815,752
|
|
|
636,461
|
|
|
10,411
|
|
|
31,518
|
|
|
(3,427,267
|
)
|
|
66,875
|
|
||||||
|
Other assets, net
|
|
15,393
|
|
|
423,901
|
|
|
75,197
|
|
|
1,199
|
|
|
(258,752
|
)
|
|
256,938
|
|
||||||
|
Total assets
|
|
$
|
3,496,579
|
|
|
$
|
3,431,010
|
|
|
$
|
1,041,474
|
|
|
$
|
94,198
|
|
|
$
|
(4,002,352
|
)
|
|
$
|
4,060,909
|
|
|
Current liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Accounts payable
|
|
$
|
316,652
|
|
|
$
|
100,570
|
|
|
$
|
122,564
|
|
|
$
|
10,649
|
|
|
$
|
(300,822
|
)
|
|
$
|
249,613
|
|
|
Accrued liabilities
|
|
8,334
|
|
|
134,452
|
|
|
26,688
|
|
|
1,282
|
|
|
(15,511
|
)
|
|
155,245
|
|
||||||
|
Total current liabilities
|
|
324,986
|
|
|
235,022
|
|
|
149,252
|
|
|
11,931
|
|
|
(316,333
|
)
|
|
404,858
|
|
||||||
|
Long-term debt
|
|
752,990
|
|
|
10,889
|
|
|
252,973
|
|
|
—
|
|
|
(252,973
|
)
|
|
763,879
|
|
||||||
|
Deferred income taxes
|
|
—
|
|
|
260,171
|
|
|
182,855
|
|
|
729
|
|
|
(5,779
|
)
|
|
437,976
|
|
||||||
|
Other liabilities
|
|
—
|
|
|
34,571
|
|
|
962
|
|
|
60
|
|
|
—
|
|
|
35,593
|
|
||||||
|
Total equity
|
|
2,418,603
|
|
|
2,890,357
|
|
|
455,432
|
|
|
81,478
|
|
|
(3,427,267
|
)
|
|
2,418,603
|
|
||||||
|
Total liabilities and equity
|
|
$
|
3,496,579
|
|
|
$
|
3,431,010
|
|
|
$
|
1,041,474
|
|
|
$
|
94,198
|
|
|
$
|
(4,002,352
|
)
|
|
$
|
4,060,909
|
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
|
Statement of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Net sales
|
|
$
|
—
|
|
|
$
|
1,026,282
|
|
|
$
|
392,008
|
|
|
$
|
208,313
|
|
|
$
|
(373,376
|
)
|
|
$
|
1,253,227
|
|
|
Cost of sales
|
|
—
|
|
|
831,675
|
|
|
227,015
|
|
|
202,110
|
|
|
(369,093
|
)
|
|
891,707
|
|
||||||
|
Gross profit
|
|
—
|
|
|
194,607
|
|
|
164,993
|
|
|
6,203
|
|
|
(4,283
|
)
|
|
361,520
|
|
||||||
|
Selling, general and administrative expenses
|
|
399
|
|
|
36,445
|
|
|
8,014
|
|
|
14,184
|
|
|
(4,283
|
)
|
|
54,759
|
|
||||||
|
(Loss) income from operations
|
|
(399
|
)
|
|
158,162
|
|
|
156,979
|
|
|
(7,981
|
)
|
|
—
|
|
|
306,761
|
|
||||||
|
Interest expense
|
|
(10,343
|
)
|
|
(2
|
)
|
|
(2,137
|
)
|
|
(39
|
)
|
|
3,035
|
|
|
(9,486
|
)
|
||||||
|
Other income (expense), net
|
|
2,138
|
|
|
(2,942
|
)
|
|
486
|
|
|
683
|
|
|
(3,035
|
)
|
|
(2,670
|
)
|
||||||
|
(Loss) income before income taxes
|
|
(8,604
|
)
|
|
155,218
|
|
|
155,328
|
|
|
(7,337
|
)
|
|
—
|
|
|
294,605
|
|
||||||
|
(Benefit from) provision for income taxes
|
|
(3,088
|
)
|
|
93,366
|
|
|
36,309
|
|
|
(2,138
|
)
|
|
—
|
|
|
124,449
|
|
||||||
|
Equity in net income of subsidiaries
|
|
173,273
|
|
|
113,157
|
|
|
—
|
|
|
5,862
|
|
|
(292,292
|
)
|
|
—
|
|
||||||
|
Net income (loss)
|
|
167,757
|
|
|
175,009
|
|
|
119,019
|
|
|
663
|
|
|
(292,292
|
)
|
|
170,156
|
|
||||||
|
Net income attributable to noncontrolling interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,399
|
|
|
—
|
|
|
2,399
|
|
||||||
|
Net income (loss) attributable to Westlake Chemical Corporation
|
|
$
|
167,757
|
|
|
$
|
175,009
|
|
|
$
|
119,019
|
|
|
$
|
(1,736
|
)
|
|
$
|
(292,292
|
)
|
|
$
|
167,757
|
|
|
Comprehensive income (loss) attributable to Westlake Chemical
Corporation
|
|
$
|
131,456
|
|
|
$
|
175,137
|
|
|
$
|
119,019
|
|
|
$
|
(39,528
|
)
|
|
$
|
(254,628
|
)
|
|
$
|
131,456
|
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
|
Statement of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Net sales
|
|
$
|
—
|
|
|
$
|
844,081
|
|
|
$
|
540,133
|
|
|
$
|
13,337
|
|
|
$
|
(393,386
|
)
|
|
$
|
1,004,165
|
|
|
Cost of sales
|
|
—
|
|
|
754,037
|
|
|
327,152
|
|
|
11,891
|
|
|
(393,386
|
)
|
|
699,694
|
|
||||||
|
Gross profit
|
|
—
|
|
|
90,044
|
|
|
212,981
|
|
|
1,446
|
|
|
—
|
|
|
304,471
|
|
||||||
|
Selling, general and administrative expenses
|
|
514
|
|
|
29,323
|
|
|
6,391
|
|
|
1,641
|
|
|
—
|
|
|
37,869
|
|
||||||
|
(Loss) income from operations
|
|
(514
|
)
|
|
60,721
|
|
|
206,590
|
|
|
(195
|
)
|
|
—
|
|
|
266,602
|
|
||||||
|
Interest expense
|
|
(3,292
|
)
|
|
(5
|
)
|
|
(2,295
|
)
|
|
—
|
|
|
2,295
|
|
|
(3,297
|
)
|
||||||
|
Other income (expense), net
|
|
3,585
|
|
|
(2,688
|
)
|
|
1,162
|
|
|
(51
|
)
|
|
(2,295
|
)
|
|
(287
|
)
|
||||||
|
(Loss) income before income taxes
|
|
(221
|
)
|
|
58,028
|
|
|
205,457
|
|
|
(246
|
)
|
|
—
|
|
|
263,018
|
|
||||||
|
(Benefit from) provision for income taxes
|
|
(70
|
)
|
|
19,973
|
|
|
72,876
|
|
|
(51
|
)
|
|
—
|
|
|
92,728
|
|
||||||
|
Equity in net income of subsidiaries
|
|
170,441
|
|
|
132,581
|
|
|
—
|
|
|
—
|
|
|
(303,022
|
)
|
|
—
|
|
||||||
|
Net income (loss) attributable to Westlake Chemical Corporation
|
|
$
|
170,290
|
|
|
$
|
170,636
|
|
|
$
|
132,581
|
|
|
$
|
(195
|
)
|
|
$
|
(303,022
|
)
|
|
$
|
170,290
|
|
|
Comprehensive income attributable to Westlake Chemical
Corporation
|
|
$
|
171,095
|
|
|
$
|
170,764
|
|
|
$
|
132,581
|
|
|
$
|
351
|
|
|
$
|
(303,696
|
)
|
|
$
|
171,095
|
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
|
Statement of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Net sales
|
|
$
|
—
|
|
|
$
|
2,809,844
|
|
|
$
|
1,476,157
|
|
|
$
|
229,183
|
|
|
$
|
(1,235,705
|
)
|
|
$
|
3,279,479
|
|
|
Cost of sales
|
|
—
|
|
|
2,476,608
|
|
|
832,304
|
|
|
221,233
|
|
|
(1,205,167
|
)
|
|
2,324,978
|
|
||||||
|
Gross profit
|
|
—
|
|
|
333,236
|
|
|
643,853
|
|
|
7,950
|
|
|
(30,538
|
)
|
|
954,501
|
|
||||||
|
Selling, general and administrative expenses
|
|
1,474
|
|
|
123,050
|
|
|
21,957
|
|
|
16,954
|
|
|
(30,538
|
)
|
|
132,897
|
|
||||||
|
(Loss) income from operations
|
|
(1,474
|
)
|
|
210,186
|
|
|
621,896
|
|
|
(9,004
|
)
|
|
—
|
|
|
821,604
|
|
||||||
|
Interest expense
|
|
(29,032
|
)
|
|
(8
|
)
|
|
(9,833
|
)
|
|
(39
|
)
|
|
10,730
|
|
|
(28,182
|
)
|
||||||
|
Other income (expense), net
|
|
14,488
|
|
|
(1,729
|
)
|
|
3,135
|
|
|
(724
|
)
|
|
(10,730
|
)
|
|
4,440
|
|
||||||
|
(Loss) income before income taxes
|
|
(16,018
|
)
|
|
208,449
|
|
|
615,198
|
|
|
(9,767
|
)
|
|
—
|
|
|
797,862
|
|
||||||
|
(Benefit from) provision for income taxes
|
|
(5,686
|
)
|
|
109,920
|
|
|
198,461
|
|
|
(2,464
|
)
|
|
—
|
|
|
300,231
|
|
||||||
|
Equity in net income of subsidiaries
|
|
505,564
|
|
|
410,875
|
|
|
—
|
|
|
5,862
|
|
|
(922,301
|
)
|
|
—
|
|
||||||
|
Net income (loss)
|
|
495,232
|
|
|
509,404
|
|
|
416,737
|
|
|
(1,441
|
)
|
|
(922,301
|
)
|
|
497,631
|
|
||||||
|
Net income attributable to noncontrolling interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,399
|
|
|
—
|
|
|
2,399
|
|
||||||
|
Net income (loss) attributable to Westlake Chemical Corporation
|
|
$
|
495,232
|
|
|
$
|
509,404
|
|
|
$
|
416,737
|
|
|
$
|
(3,840
|
)
|
|
$
|
(922,301
|
)
|
|
$
|
495,232
|
|
|
Comprehensive income (loss) attributable to Westlake Chemical
Corporation
|
|
$
|
461,415
|
|
|
$
|
509,787
|
|
|
$
|
416,737
|
|
|
$
|
(41,722
|
)
|
|
$
|
(884,802
|
)
|
|
$
|
461,415
|
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
|
Statement of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Net sales
|
|
$
|
—
|
|
|
$
|
2,407,341
|
|
|
$
|
1,565,809
|
|
|
$
|
37,561
|
|
|
$
|
(1,202,852
|
)
|
|
$
|
2,807,859
|
|
|
Cost of sales
|
|
—
|
|
|
2,247,338
|
|
|
924,663
|
|
|
32,943
|
|
|
(1,202,852
|
)
|
|
2,002,092
|
|
||||||
|
Gross profit
|
|
—
|
|
|
160,003
|
|
|
641,146
|
|
|
4,618
|
|
|
—
|
|
|
805,767
|
|
||||||
|
Selling, general and administrative expenses
|
|
1,576
|
|
|
84,152
|
|
|
19,326
|
|
|
4,829
|
|
|
—
|
|
|
109,883
|
|
||||||
|
(Loss) income from operations
|
|
(1,576
|
)
|
|
75,851
|
|
|
621,820
|
|
|
(211
|
)
|
|
—
|
|
|
695,884
|
|
||||||
|
Interest expense
|
|
(14,882
|
)
|
|
(39
|
)
|
|
(4,893
|
)
|
|
—
|
|
|
4,893
|
|
|
(14,921
|
)
|
||||||
|
Other income (expense), net
|
|
7,490
|
|
|
(4,002
|
)
|
|
6,422
|
|
|
(1,880
|
)
|
|
(4,893
|
)
|
|
3,137
|
|
||||||
|
(Loss) income before income taxes
|
|
(8,968
|
)
|
|
71,810
|
|
|
623,349
|
|
|
(2,091
|
)
|
|
—
|
|
|
684,100
|
|
||||||
|
(Benefit from) provision for income taxes
|
|
(3,202
|
)
|
|
27,292
|
|
|
221,009
|
|
|
(452
|
)
|
|
—
|
|
|
244,647
|
|
||||||
|
Equity in net income of subsidiaries
|
|
445,219
|
|
|
402,340
|
|
|
—
|
|
|
—
|
|
|
(847,559
|
)
|
|
—
|
|
||||||
|
Net income (loss) attributable to Westlake Chemical Corporation
|
|
$
|
439,453
|
|
|
$
|
446,858
|
|
|
$
|
402,340
|
|
|
$
|
(1,639
|
)
|
|
$
|
(847,559
|
)
|
|
$
|
439,453
|
|
|
Comprehensive income (loss) attributable to Westlake Chemical
Corporation
|
|
$
|
439,372
|
|
|
$
|
447,490
|
|
|
$
|
402,340
|
|
|
$
|
(2,483
|
)
|
|
$
|
(847,347
|
)
|
|
$
|
439,372
|
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
|
Statement of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Cash flows from operating activities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Net income (loss)
|
|
$
|
495,232
|
|
|
$
|
509,404
|
|
|
$
|
416,737
|
|
|
$
|
(1,441
|
)
|
|
$
|
(922,301
|
)
|
|
$
|
497,631
|
|
|
Adjustments to reconcile net income (loss) to net cash (used for)
provided by operating activities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Depreciation and amortization
|
|
1,172
|
|
|
82,597
|
|
|
58,501
|
|
|
7,296
|
|
|
—
|
|
|
149,566
|
|
||||||
|
Deferred income taxes
|
|
(418
|
)
|
|
26,991
|
|
|
8,267
|
|
|
(381
|
)
|
|
—
|
|
|
34,459
|
|
||||||
|
Net changes in working capital and other
|
|
(509,862
|
)
|
|
(919,521
|
)
|
|
1,641
|
|
|
599,909
|
|
|
922,301
|
|
|
94,468
|
|
||||||
|
Net cash (used for) provided by operating activities
|
|
(13,876
|
)
|
|
(300,529
|
)
|
|
485,146
|
|
|
605,383
|
|
|
—
|
|
|
776,124
|
|
||||||
|
Cash flows from investing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Acquisition of business, net of cash acquired
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(611,087
|
)
|
|
—
|
|
|
(611,087
|
)
|
||||||
|
Additions to property, plant and equipment
|
|
—
|
|
|
(160,147
|
)
|
|
(144,348
|
)
|
|
(6,688
|
)
|
|
—
|
|
|
(311,183
|
)
|
||||||
|
Proceeds from disposition of assets
|
|
—
|
|
|
144
|
|
|
—
|
|
|
1
|
|
|
—
|
|
|
145
|
|
||||||
|
Proceeds from repayment of loan acquired
|
|
—
|
|
|
—
|
|
|
—
|
|
|
45,923
|
|
|
—
|
|
|
45,923
|
|
||||||
|
Proceeds from sales and maturities of securities
|
|
342,045
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
342,045
|
|
||||||
|
Purchase of securities
|
|
(117,332
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(117,332
|
)
|
||||||
|
Settlements of derivative instruments
|
|
—
|
|
|
(556
|
)
|
|
(133
|
)
|
|
—
|
|
|
—
|
|
|
(689
|
)
|
||||||
|
Net cash provided by (used for) investing activities
|
|
224,713
|
|
|
(160,559
|
)
|
|
(144,481
|
)
|
|
(571,851
|
)
|
|
—
|
|
|
(652,178
|
)
|
||||||
|
Cash flows from financing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Intercompany financing
|
|
75,104
|
|
|
(143,325
|
)
|
|
62,221
|
|
|
6,000
|
|
|
—
|
|
|
—
|
|
||||||
|
Net distributions prior to WLKP initial public offering
|
|
—
|
|
|
448,101
|
|
|
(448,101
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Capitalized debt issuance costs
|
|
(1,167
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,167
|
)
|
||||||
|
Dividends paid
|
|
(55,690
|
)
|
|
151,729
|
|
|
(151,729
|
)
|
|
—
|
|
|
—
|
|
|
(55,690
|
)
|
||||||
|
Net proceeds from issuance of WLKP common units
|
|
—
|
|
|
—
|
|
|
—
|
|
|
286,088
|
|
|
—
|
|
|
286,088
|
|
||||||
|
Purchase of limited partner interests
|
|
—
|
|
|
—
|
|
|
286,088
|
|
|
(286,088
|
)
|
|
—
|
|
|
—
|
|
||||||
|
Proceeds from exercise of stock options
|
|
5,502
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,502
|
|
||||||
|
Repurchase of common stock for treasury
|
|
(9,495
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(9,495
|
)
|
||||||
|
Windfall tax benefits from share-based payment arrangements
|
|
6,670
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6,670
|
|
||||||
|
Net cash provided by (used for) financing activities
|
|
20,924
|
|
|
456,505
|
|
|
(251,521
|
)
|
|
6,000
|
|
|
—
|
|
|
231,908
|
|
||||||
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
|
Effect of exchange rate changes on cash and cash equivalents
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(3,687
|
)
|
|
—
|
|
|
(3,687
|
)
|
||||||
|
Net increase (decrease) in cash and cash equivalents
|
|
231,761
|
|
|
(4,583
|
)
|
|
89,144
|
|
|
35,845
|
|
|
—
|
|
|
352,167
|
|
||||||
|
Cash and cash equivalents at beginning of period
|
|
420,948
|
|
|
6,227
|
|
|
—
|
|
|
34,126
|
|
|
—
|
|
|
461,301
|
|
||||||
|
Cash and cash equivalents at end of period
|
|
$
|
652,709
|
|
|
$
|
1,644
|
|
|
$
|
89,144
|
|
|
$
|
69,971
|
|
|
$
|
—
|
|
|
$
|
813,468
|
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
|
Statement of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Cash flows from operating activities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Net income (loss)
|
|
$
|
439,453
|
|
|
$
|
446,858
|
|
|
$
|
402,340
|
|
|
$
|
(1,639
|
)
|
|
$
|
(847,559
|
)
|
|
$
|
439,453
|
|
|
Adjustments to reconcile net income (loss) to net cash (used for)
provided by operating activities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Depreciation and amortization
|
|
1,094
|
|
|
59,893
|
|
|
54,539
|
|
|
1,861
|
|
|
—
|
|
|
117,387
|
|
||||||
|
Deferred income taxes
|
|
(1,102
|
)
|
|
57,279
|
|
|
27,253
|
|
|
13
|
|
|
—
|
|
|
83,443
|
|
||||||
|
Net changes in working capital and other
|
|
(458,336
|
)
|
|
(421,066
|
)
|
|
(68,604
|
)
|
|
7,664
|
|
|
847,559
|
|
|
(92,783
|
)
|
||||||
|
Net cash (used for) provided by operating activities
|
|
(18,891
|
)
|
|
142,964
|
|
|
415,528
|
|
|
7,899
|
|
|
—
|
|
|
547,500
|
|
||||||
|
Cash flows from investing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Acquisition of business
|
|
—
|
|
|
(178,309
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(178,309
|
)
|
||||||
|
Additions to equity investments
|
|
—
|
|
|
(23,338
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(23,338
|
)
|
||||||
|
Additions to property, plant and equipment
|
|
—
|
|
|
(337,158
|
)
|
|
(158,869
|
)
|
|
(2,263
|
)
|
|
—
|
|
|
(498,290
|
)
|
||||||
|
Construction of assets pending sale-leaseback
|
|
—
|
|
|
(136
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(136
|
)
|
||||||
|
Proceeds from disposition of assets
|
|
—
|
|
|
6
|
|
|
—
|
|
|
72
|
|
|
—
|
|
|
78
|
|
||||||
|
Proceeds from repayment of loan to affiliate
|
|
—
|
|
|
—
|
|
|
—
|
|
|
167
|
|
|
—
|
|
|
167
|
|
||||||
|
Proceeds from sales and maturities of securities
|
|
239,764
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
239,764
|
|
||||||
|
Purchase of securities
|
|
(232,286
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(232,286
|
)
|
||||||
|
Settlements of derivative instruments
|
|
—
|
|
|
—
|
|
|
(2,297
|
)
|
|
—
|
|
|
—
|
|
|
(2,297
|
)
|
||||||
|
Net cash provided by (used for) investing activities
|
|
7,478
|
|
|
(538,935
|
)
|
|
(161,166
|
)
|
|
(2,024
|
)
|
|
—
|
|
|
(694,647
|
)
|
||||||
|
Cash flows from financing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Intercompany financing
|
|
(130,832
|
)
|
|
(28,499
|
)
|
|
167,629
|
|
|
(8,298
|
)
|
|
—
|
|
|
—
|
|
||||||
|
Net distributions prior to WLKP initial public offering
|
|
—
|
|
|
421,991
|
|
|
(421,991
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Dividends paid
|
|
(40,204
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(40,204
|
)
|
||||||
|
Proceeds from exercise of stock options
|
|
3,182
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3,182
|
|
||||||
|
Repurchase of common stock for treasury
|
|
(19,409
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(19,409
|
)
|
||||||
|
Windfall tax benefits from share-based payment arrangements
|
|
5,056
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,056
|
|
||||||
|
Net cash (used for) provided by financing activities
|
|
(182,207
|
)
|
|
393,492
|
|
|
(254,362
|
)
|
|
(8,298
|
)
|
|
—
|
|
|
(51,375
|
)
|
||||||
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
OpCo
(Less Than
100% Owned
Guarantor
Subsidiary)
|
|
Non-
Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||||
|
Net decrease in cash and cash equivalents
|
|
(193,620
|
)
|
|
(2,479
|
)
|
|
—
|
|
|
(2,423
|
)
|
|
—
|
|
|
(198,522
|
)
|
||||||
|
Cash and cash equivalents at beginning of period
|
|
753,881
|
|
|
6,973
|
|
|
—
|
|
|
29,224
|
|
|
—
|
|
|
790,078
|
|
||||||
|
Cash and cash equivalents at end of period
|
|
$
|
560,261
|
|
|
$
|
4,494
|
|
|
$
|
—
|
|
|
$
|
26,801
|
|
|
$
|
—
|
|
|
$
|
591,556
|
|
|
Item 2.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
(dollars in thousands, except per share data)
|
||||||||||||||
|
Net external sales
|
|
|
|
|
|
|
|
|
||||||||
|
Olefins
|
|
|
|
|
|
|
|
|
||||||||
|
Polyethylene
|
|
$
|
498,450
|
|
|
$
|
460,105
|
|
|
$
|
1,461,097
|
|
|
$
|
1,294,566
|
|
|
Styrene, feedstock and other
|
|
204,647
|
|
|
219,234
|
|
|
663,851
|
|
|
590,959
|
|
||||
|
Total Olefins
|
|
703,097
|
|
|
679,339
|
|
|
2,124,948
|
|
|
1,885,525
|
|
||||
|
Vinyls
|
|
|
|
|
|
|
|
|
||||||||
|
PVC, caustic soda and other
|
|
416,771
|
|
|
212,041
|
|
|
776,060
|
|
|
612,391
|
|
||||
|
Building products
|
|
133,359
|
|
|
112,785
|
|
|
378,471
|
|
|
309,943
|
|
||||
|
Total Vinyls
|
|
550,130
|
|
|
324,826
|
|
|
1,154,531
|
|
|
922,334
|
|
||||
|
Total
|
|
$
|
1,253,227
|
|
|
$
|
1,004,165
|
|
|
$
|
3,279,479
|
|
|
$
|
2,807,859
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Income (loss) from operations
|
|
|
|
|
|
|
|
|
||||||||
|
Olefins
|
|
$
|
259,277
|
|
|
$
|
237,239
|
|
|
$
|
770,267
|
|
|
$
|
585,958
|
|
|
Vinyls
|
|
59,445
|
|
|
39,554
|
|
|
76,460
|
|
|
136,123
|
|
||||
|
Corporate and other
|
|
(11,961
|
)
|
|
(10,191
|
)
|
|
(25,123
|
)
|
|
(26,197
|
)
|
||||
|
Total income from operations
|
|
306,761
|
|
|
266,602
|
|
|
821,604
|
|
|
695,884
|
|
||||
|
Interest expense
|
|
(9,486
|
)
|
|
(3,297
|
)
|
|
(28,182
|
)
|
|
(14,921
|
)
|
||||
|
Other (expense) income, net
|
|
(2,670
|
)
|
|
(287
|
)
|
|
4,440
|
|
|
3,137
|
|
||||
|
Provision for income taxes
|
|
124,449
|
|
|
92,728
|
|
|
300,231
|
|
|
244,647
|
|
||||
|
Net income
|
|
170,156
|
|
|
170,290
|
|
|
497,631
|
|
|
439,453
|
|
||||
|
Net income attributable to noncontrolling
interests
|
|
2,399
|
|
|
—
|
|
|
2,399
|
|
|
—
|
|
||||
|
Net income attributable to Westlake Chemical
Corporation
|
|
$
|
167,757
|
|
|
$
|
170,290
|
|
|
$
|
495,232
|
|
|
$
|
439,453
|
|
|
Diluted earnings per share
(1)
|
|
$
|
1.25
|
|
|
$
|
1.27
|
|
|
$
|
3.69
|
|
|
$
|
3.27
|
|
|
_____________
|
|
|
|
|
|
|
|
|
||||||||
|
(1) Per share data for the three and nine months ended September 30, 2013 have been restated to reflect the effect of
a two-for-one stock split on March 18, 2014. See Note 1 to the unaudited consolidated financial statements within
this Quarterly Report on Form 10-Q for additional information.
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
Three Months Ended September 30, 2014
|
|
Nine Months Ended September 30, 2014
|
||||||||||||
|
|
|
Average
Sales Price
|
|
Volume
|
|
Average
Sales Price
|
|
Volume
|
||||||||
|
Product sales price and volume percentage change
from prior year period
|
|
|
|
|
|
|
|
|
||||||||
|
Olefins
|
|
+10.7
|
%
|
|
-7.2
|
%
|
|
+9.8
|
%
|
|
+2.9
|
%
|
||||
|
Vinyls
|
|
+1.6
|
%
|
|
+67.8
|
%
|
|
-0.2
|
%
|
|
+25.3
|
%
|
||||
|
Company average
|
|
+7.8
|
%
|
|
+17.1
|
%
|
|
+6.6
|
%
|
|
+10.2
|
%
|
||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
|
Average industry prices
(1)
|
|
|
|
|
|
|
|
|
||||||||
|
Ethane (cents/lb)
|
|
7.9
|
|
|
8.4
|
|
|
9.7
|
|
|
8.7
|
|
||||
|
Propane (cents/lb)
|
|
24.6
|
|
|
24.4
|
|
|
26.9
|
|
|
22.2
|
|
||||
|
Ethylene (cents/lb)
(2)
|
|
66.6
|
|
|
54.3
|
|
|
59.1
|
|
|
58.7
|
|
||||
|
Polyethylene (cents/lb)
(3)
|
|
110.0
|
|
|
101.7
|
|
|
108.9
|
|
|
99.7
|
|
||||
|
Styrene (cents/lb)
(4)
|
|
85.8
|
|
|
83.2
|
|
|
85.0
|
|
|
83.6
|
|
||||
|
Caustic soda ($/short ton)
(5)
|
|
588.3
|
|
|
605.8
|
|
|
587.5
|
|
|
611.4
|
|
||||
|
Chlorine ($/short ton)
(6)
|
|
232.5
|
|
|
248.3
|
|
|
233.9
|
|
|
252.8
|
|
||||
|
PVC (cents/lb)
(7)
|
|
70.2
|
|
|
61.5
|
|
|
68.7
|
|
|
60.9
|
|
||||
|
(1)
|
Industry pricing data was obtained from IHS Chemical. We have not independently verified the data.
|
|
(2)
|
Represents average North American spot prices of ethylene over the period as reported by IHS Chemical.
|
|
(3)
|
Represents average North American contract prices of polyethylene low density film over the period as reported by IHS Chemical.
|
|
(4)
|
Represents average North American contract prices of styrene over the period as reported by IHS Chemical.
|
|
(5)
|
Represents average North American undiscounted contract prices of caustic soda over the period as reported by IHS Chemical.
|
|
(6)
|
Represents average North American contract prices of chlorine (into chemicals) over the period as reported by IHS Chemical.
|
|
(7)
|
Represents average North American contract prices of PVC over the period as reported by IHS Chemical.
|
|
•
|
future operating rates, margins, cash flow and demand for our products;
|
|
•
|
industry market outlook, including the price of crude oil;
|
|
•
|
production capacities;
|
|
•
|
our ability to borrow additional funds under our credit facility;
|
|
•
|
our ability to meet our liquidity needs;
|
|
•
|
our intended quarterly dividends;
|
|
•
|
future capacity additions and expansions in the industry;
|
|
•
|
timing, funding and results of the expansion program at our Lake Charles complex;
|
|
•
|
results of the new chlor-alkali plant in Geismar;
|
|
•
|
results of the feedstock conversion program at our Calvert City ethylene plant;
|
|
•
|
results of the Vinnolit acquisition;
|
|
•
|
estimated annual tax rate for the year 2014;
|
|
•
|
pension plan funding requirements and investment policies;
|
|
•
|
compliance with present and future environmental regulations and costs associated with environmentally related penalties, capital expenditures, remedial actions and proceedings, including any new laws, regulations or treaties
|
|
•
|
effects of pending legal proceedings; and
|
|
•
|
timing of and amount of capital expenditures.
|
|
•
|
general economic and business conditions;
|
|
•
|
the cyclical nature of the chemical industry;
|
|
•
|
the availability, cost and volatility of raw materials and energy;
|
|
•
|
uncertainties associated with the United States and worldwide economies, including those due to political tensions in the Middle East and elsewhere;
|
|
•
|
current and potential governmental regulatory actions in the United States and regulatory actions and political unrest in other countries;
|
|
•
|
industry production capacity and operating rates;
|
|
•
|
the supply/demand balance for our products;
|
|
•
|
competitive products and pricing pressures;
|
|
•
|
instability in the credit and financial markets;
|
|
•
|
access to capital markets;
|
|
•
|
terrorist acts;
|
|
•
|
operating interruptions (including leaks, explosions, fires, weather-related incidents, mechanical failure, unscheduled downtime, labor difficulties, transportation interruptions, spills and releases and other environmental risks);
|
|
•
|
changes in laws or regulations;
|
|
•
|
technological developments;
|
|
•
|
our ability to integrate acquired businesses;
|
|
•
|
foreign currency exchange risks;
|
|
•
|
our ability to implement our business strategies; and
|
|
•
|
creditworthiness of our customers.
|
|
Item 3.
|
Quantitative and Qualitative Disclosures about Market Risk
|
|
Item 4.
|
Controls and Procedures
|
|
Item 1.
|
Legal Proceedings
|
|
Item 1A.
|
Risk Factors
|
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
|
Period
|
|
Total Number
of Shares
Purchased
(1)
|
|
Average Price
Paid Per
Share
|
|
Total Number
of Shares
Purchased as Part
of Publicly
Announced Plans
or Programs
(1)
|
|
Maximum Number
(or Approximate
Dollar Value) of
Shares that
May Yet Be
Purchased Under the
Plans or Programs
(1)
|
||||||
|
July 2014
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
53,780,000
|
|
|
August 2014
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
53,780,000
|
|
|
September 2014
|
|
104,163
|
|
|
$
|
91.16
|
|
|
104,163
|
|
|
$
|
44,285,000
|
|
|
|
|
104,163
|
|
|
$
|
91.16
|
|
|
104,163
|
|
|
|
||
|
(1)
|
On August 22, 2011, we announced the authorization by our Board of Directors of a $100.0 million stock repurchase program. As of
September 30, 2014
,
1,357,085
shares of common stock (on a post-split basis) had been acquired at an aggregate purchase price of
$55.7 million
. Decisions regarding the amount and the timing of purchases under the program will be influenced by our cash on hand, our cash flow from operations, general market conditions and other factors. The program may be discontinued by our Board of Directors at any time.
|
|
Item 6.
|
Exhibits
|
|
Exhibit No.
|
|
|
|
|
|
|
|
4.1
|
|
Supplemental Indenture dated as of July 17, 2014 among Westlake Chemical OpCo LP, Westlake Chemical Corporation, the other Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Westlake Chemical Corporation’s Quarterly Report on Form 10-Q, filed on August 6, 2014, File No. 001-32260).
|
|
|
|
|
|
10.1
|
|
Third Amended and Restated Credit Agreement dated as of July 17, 2014 by and among the financial institutions party thereto, as lenders, Bank of America, N.A., as agent, and Westlake Chemical Corporation and certain of its domestic subsidiaries, as borrowers, relating to a $400.0 million senior secured revolving credit facility (incorporated by reference to Westlake Chemical Corporation’s Current Report on Form 8-K, filed on July 17, 2014, File No. 001-32260).
|
|
|
|
|
|
31.1
|
|
Rule 13a – 14(a) / 15d – 14(a) Certification (Principal Executive Officer)
|
|
|
|
|
|
31.2
|
|
Rule 13a – 14(a) / 15d – 14(a) Certification (Principal Financial Officer)
|
|
|
|
|
|
32.1
|
|
Section 1350 Certification (Principal Executive Officer and Principal Financial Officer)
|
|
|
|
|
|
99.1
|
|
Unaudited Financial Statements of Non Wholly-Owned Subsidiary Guarantor (Westlake Chemical OpCo LP)
|
|
|
|
|
|
101.INS
|
|
XBRL Instance Document
|
|
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
WESTLAKE CHEMICAL CORPORATION
|
||
|
|
|
|
|
|||
|
Date:
|
November 7, 2014
|
|
|
By:
|
|
/
S
/ A
LBERT
C
HAO
|
|
|
|
|
|
|
|
Albert Chao
|
|
|
|
|
|
|
|
President and Chief Executive Officer
(Principal Executive Officer)
|
|
|
|
|
|
|||
|
Date:
|
November 7, 2014
|
|
|
By:
|
|
/
S
/ M. S
TEVEN
B
ENDER
|
|
|
|
|
|
|
|
M. Steven Bender
|
|
|
|
|
|
|
|
Senior Vice President, Chief Financial Officer
and Treasurer
(Principal Financial Officer)
|
|
Exhibit No.
|
|
Exhibit
|
|
|
|
|
|
4.1
|
|
Supplemental Indenture dated as of July 17, 2014 among Westlake Chemical OpCo LP, Westlake Chemical Corporation, the other Subsidiary Guarantors (as defined therein) and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Westlake Chemical Corporation’s Quarterly Report on Form 10-Q, filed on August 6, 2014, File No. 001-32260).
|
|
|
|
|
|
10.1
|
|
Third Amended and Restated Credit Agreement dated as of July 17, 2014 by and among the financial institutions party thereto, as lenders, Bank of America, N.A., as agent, and Westlake Chemical Corporation and certain of its domestic subsidiaries, as borrowers, relating to a $400.0 million senior secured revolving credit facility (incorporated by reference to Westlake Chemical Corporation’s Current Report on Form 8-K, filed on July 17, 2014, File No. 001-32260).
|
|
|
|
|
|
31.1
|
|
Rule 13a – 14(a) / 15d – 14(a) Certification (Principal Executive Officer)
|
|
|
|
|
|
31.2
|
|
Rule 13a – 14(a) / 15d – 14(a) Certification (Principal Financial Officer)
|
|
|
|
|
|
32.1
|
|
Section 1350 Certification (Principal Executive Officer and Principal Financial Officer)
|
|
|
|
|
|
99.1
|
|
Unaudited Financial Statements of Non Wholly-Owned Subsidiary Guarantor (Westlake Chemical OpCo LP)
|
|
|
|
|
|
101.INS
|
|
XBRL Instance Document
|
|
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Customers
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|